PRCT Procept BioRobotics Corp
447
$64.48
3.62%
| Watchers | 447 |
| 52-Wk Low | $24.83 |
| 52-Wk High | $77.00 |
| Market Cap | $3.32B |
| Volume | 630,047.00 |
| 52-Wk High | $77.00 |
| 52-Wk Low | $24.83 |
Unveiling 4 Analyst Insights On PROCEPT BioRoboticsBenzinga • 22 days ago
Latest Ratings for PRCT
DateFirmActionFromTo Mar 2022B of A SecuritiesMaintainsBuy Mar 2022SVB LeerinkMaintainsOutperform Nov 2021SVB LeerinkMaintainsOutperform
View More Analyst Ratings for...
Share to Feed
PROCEPT BioRobotics Co. (NASDAQ:PRCT - Get Free Report) has been assigned a consensus recommendation of "Buy" from the six analysts that are presently covering the company, MarketBeat reports. Six...
SAN JOSE, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative...
SAN JOSE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (the Company ) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing...
PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) - Stock analysts at Leerink Partnrs issued their Q2 2025 earnings per share estimates for shares of PROCEPT BioRobotics in a research report...
Accelerate Diagnostics (AXDX) came out with a quarterly loss of $0.89 per share versus the Zacks Consensus Estimate of a loss of $0.62. This compares to loss of $1.40 per share a year ago. These...
Related Stocks: PRCT...
Investors in PROCEPT BioRobotics Corp (PRCT) saw new options become available this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the...
Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT Get Free Report) have been given a consensus recommendation of Buy by the six research firms that are covering the firm...
PROCEPT BioRobotics (NASDAQ:PRCT Get Free Report) and DexCom (NASDAQ:DXCM Get Free Report) are both medical companies, but which is the superior business? We will contrast the two...